BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid... Show more
The RSI Indicator for BNTX moved out of oversold territory on September 04, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 27 similar instances when the indicator left oversold territory. In of the 27 cases the stock moved higher. This puts the odds of a move higher at .
The Momentum Indicator moved above the 0 level on October 01, 2025. You may want to consider a long position or call options on BNTX as a result. In of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for BNTX just turned positive on September 24, 2025. Looking at past instances where BNTX's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .
BNTX moved above its 50-day moving average on October 03, 2025 date and that indicates a change from a downward trend to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BNTX advanced for three days, in of 281 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The 50-day moving average for BNTX moved below the 200-day moving average on September 18, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BNTX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
BNTX broke above its upper Bollinger Band on October 01, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for BNTX entered a downward trend on September 09, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. BNTX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.176) is normal, around the industry mean (23.421). P/E Ratio (161.759) is within average values for comparable stocks, (54.441). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.237). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (7.570) is also within normal values, averaging (342.085).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BNTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
a company, which focuses on the development of molecular immune therapies and biomarker-based diagnostic approaches
Industry Biotechnology
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
GCOW | 39.88 | -0.10 | -0.25% |
Pacer Global Cash Cows Dividend ETF | |||
NUMV | 38.73 | -0.20 | -0.53% |
Nuveen ESG Mid-Cap Value ETF | |||
LOPP | 32.18 | -0.20 | -0.62% |
Gabelli Love Our Planet & People ETF | |||
RAYD | 37.78 | -0.26 | -0.69% |
Rayliant Quantitative Dev Mkt Eq ETF | |||
VRTL | 53.50 | -2.73 | -4.85% |
GraniteShares 2x Long VRT Daily ETF |
A.I.dvisor indicates that over the last year, BNTX has been loosely correlated with MRNA. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if BNTX jumps, then MRNA could also see price increases.
Ticker / NAME | Correlation To BNTX | 1D Price Change % | ||
---|---|---|---|---|
BNTX | 100% | +0.86% | ||
MRNA - BNTX | 55% Loosely correlated | -0.73% | ||
SMMT - BNTX | 49% Loosely correlated | +0.63% | ||
KYMR - BNTX | 48% Loosely correlated | -1.09% | ||
TIL - BNTX | 44% Loosely correlated | +0.81% | ||
ARCT - BNTX | 43% Loosely correlated | -2.57% | ||
More |